Article Details
Retrieved on: 2024-12-23 22:24:59
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
And in a separate transaction, Akamis Bio entered into a licensing agreement granting Xuanzhu Biopharma the Greater China Region Rights to NG-350A.
Article found on: pulse2.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here